Herceptin Hylecta and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Herceptin Hylecta and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: n.a.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Herceptin Hylecta-Lithium ER
- Herceptin Hylecta-Lithium Oral Solution
- Herceptin Hylecta-Lithium Salts
- Herceptin Hylecta-Lithium Syrup and Oral Solution
- Herceptin Hylecta-Lithobid
- Herceptin Hylecta-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Hermes No. 8
- Lithium Controlled-Release and Extended-Release Tablets-Herzuma
- Lithium Controlled-Release and Extended-Release Tablets-Hetlioz
- Lithium Controlled-Release and Extended-Release Tablets-Hexabrix
- Lithium Controlled-Release and Extended-Release Tablets-Hexachlorophene
- Lithium Controlled-Release and Extended-Release Tablets-Hexachlorophene Topical application